SCHEMBL18705702

SCHEMBL18705702

CCC1CNCCN1C=O

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HTR2B P41595 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17294258 0.85 CYP2D6 (0.36)
Hydrochloric Acid SCHEMBL28287191 0.84 CYP2D6 (0.36)
SCHEMBL1134919 0.82 SLC6A2 (0.30)
SCHEMBL4534726 0.82 SLC6A2 (0.30)
SCHEMBL18951868 0.81 CYP2D6 (0.40)
SCHEMBL27463133 0.81 TAAR1 (0.37)
SCHEMBL30177823 0.81 CA1 (0.31)
SCHEMBL27610611 0.81
SCHEMBL22770584 0.80 CYP2D6 (0.38)
SCHEMBL30309468 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114315823-B Intermediate of berberine hydrochloride and analogues thereof and preparation method thereof 西南交通大学 2023-07-18 CN disclosed
EP-3371151-A1 COMPOUNDS FOR TREATMENT OF CANCER AND EPIGENETICS Agency For Science, Technology And Research (SG) 2018-09-12 EP disclosed
WO-2017061957-A1 COMPOUNDS FOR TREATMENT OF CANCER AND EPIGENETICS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-04-13 WO disclosed